Influence of insulin therapy on homocysteine levels in type 2 diabetes patients with secondary failure to sulfonylureas

被引:0
|
作者
Czupryniak, L
Bald, E
Drzewoski, J
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A151 / A151
页数:1
相关论文
共 50 条
  • [41] SERUM TOTAL HOMOCYSTEINE LEVELS AND METABOLIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES
    Get-ngem, Panisa
    Chantapet, Pranee
    Satitvpawee, Pratana
    Sinsatienporn, Somsak
    Boonrod, Ubon
    [J]. JOURNAL OF HEALTH RESEARCH, 2005, 19 (02) : 105 - 117
  • [42] Plasma homocysteine levels are associated with peripheral neuropathy in patients with type 2 diabetes
    Idzior-Walus, B
    Sieradzki, J
    Walus-Miarka, M
    Cieslik, G
    Wozniakiewicz, E
    [J]. DIABETES, 2005, 54 : A8 - A8
  • [43] Effect of Strength Training on Plasma Levels of Homocysteine in Patients with Type 2 Diabetes
    de Souza e Silva, Alexandre
    Lacerda, Fabio Vieira
    Goncalves da Mota, Maria Paula
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2019, 10 : 1 - 6
  • [44] The effect of rosiglitazone on lipoprotein(a) and homocysteine levels in patients with hypertension and Type 2 diabetes
    Sarafidis, P
    Lasaridis, A
    Nilsson, P
    Hitoglou-Makedou, A
    Pliakos, C
    Tziolas, I
    Hatzistavri, L
    Stafilas, P
    Tourkantonis, A
    [J]. JOURNAL OF HYPERTENSION, 2005, 23 : S96 - S96
  • [45] THE MECHANISMS OF SECONDARY DRUG FAILURE IN PATIENTS WITH TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES
    GROOP, L
    PELKONEN, R
    KOSKIMIES, S
    [J]. DIABETOLOGIA, 1982, 23 (02) : 171 - 171
  • [46] Reduced serum homocysteine levels in type 2 diabetes
    Mazza, A
    Bossone, E
    Mazza, F
    Distante, A
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2005, 15 (02) : 118 - 124
  • [47] Predictors for a successful add-on therapy with basal insulin in patients with Type 2 diabetes and secondary failure of oral antidiabetic drugs.
    Schulze, J
    Peiker, J
    Schweitzer, MA
    Fritsche, A
    Häring, HU
    [J]. DIABETOLOGIA, 2003, 46 : A275 - A275
  • [48] Predictors fora successful add-on therapy with basal insulin in patients with type 2 diabetes and secondary failure of oral hypoglycemic agents
    Schulze, J
    Peiker, J
    Schweitzer, MA
    Fritsche, A
    Häring, HU
    [J]. DIABETES, 2003, 52 : A456 - A456
  • [50] The differential influence of glimepiride and glibenclamide on insulin resistance and adiponectin levels in patients with type 2 diabetes
    Emini-Sadiku, Merita
    Car, Nikica
    Begolli, Luljeta
    Blaslov, Kristina
    Haliti, Edmond
    Bahtiri, Elton
    [J]. ENDOCRINE JOURNAL, 2019, 66 (10) : 915 - 921